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Purpose: To evaluate the patency and hemodynamic impact of a cryopreserved allograft 
venous valve transplanted to the superficial femoral vein (SFV) of a canine insufficiency 
model aided by a distal arteriovenous fi tula (dAVF). 
Methods: Eight greyhounds had intravenous hemodynamic parameters measured (venous 
filling time [VFT], 90% of venous refilling time [VRTg0], and simulated ambulatory 
venous pressure [AVP]) before (To) and after complete hindlimb venous valvulotomy 
(T1) to produce venous insufficiency. Simultaneously, a valve-containing vein segment 
was harvested from the opposite SFV or external jugular vein (n = 1) and cryopreserved. 
Three weeks later a blood type-matched cryopreserved valve was transplanted to the 
insufficient SFV aided by a low-flow (n = 4) or high-flow (n = 4) dAVF. The flstxfla was 
ligated in 3 to 6 weeks, and venous indexes (T2) were obtained 3 weeks later. Analysis of 
variances compared the venous indexes at To, T1, and T 2 for statistical significance. Gross 
and histologic inspection assessed valve integrity. 
Results: Two valves aided by a low-flow dAVF exhibited thrombosis and scarring. The 
hemodynamics of the six remaining valves demonstrated normalization of the VRT90 , an 
AVI' consistent with insufficiency, and a VFT between ormal and total venous insuffi- 
ciency. The patent valves were normal on gross examination and by histologic examina- 
tion with signs of normal external healing. 
Conclusions: A cryopreserved venous valve allograft transplanted to the SFV of an 
incompetent hindlimb partially corrects venous hemodynamics. A high-flow arterio- 
venous fistula most consistently preserves transplant patency. (J Vase Surg 1997; 
26:817-22.) 
Venous valvular incompetence is the most com- 
mon cause of lower extremity chronic venous insuf- 
ficiency. It has been shown that the venous hemo- 
dynamics of chronic venous insufficiency may be 
improved by the transplantation f a competent ve- 
nous valve. 1,2 Several attempts to provide an off- 
the-shelf valve for use in transplantation have given 
less-than-desirable r sults. 3-s The availability of a 
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cryopreserved allograft v lve suitable for transplanta- 
tion may provide a viable option. With the use of a 
chronic venous valvular insufficiency model devel- 
oped in our laboratory, 6 the patency and hemody- 
namic impact of implanting such a valve aided by a 
distal arteriovenous fi tula (dAVF) was evaluated. 
METHODS 
Intravenous hemodynamic parameters, including 
venous filling time (VFT), 90% of venous refilling 
time (VRT90), and simulated ambulatory venous 
pressure (AVP), were measured in eight greyhounds 
before (To) and after complete hindlimb venous val- 
vulotomy (T1) , producing the previously described 
chronic venous insufficiency model. 6 A catheter 
placed in the lateral saphenous vein at the paw was 
connected to a transducer (Model 156PC06GW12; 
Micro Switch, Freeport, Ill.) and chart recorder 
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(Model 3200; Gould, Inc., Cleveland). From this 
venous line, blood samples were sent for dog eryth- 
rocyte antigen (DEA) typing (Imnmnohematology 
and Serology Laboratory, Department of Medicine, 
Michigan State University, East Lansing, Mich.). 
This venous cannulation also allowed for intravenous 
monitoring while the dog was in the supine position 
and after tilting to the semierect position. VFT was 
the time between table tilting and venous pressure 
plateau. Vigorous exercise was simulated with electri- 
cal stimulation of the biceps femoris and gracifis 
muscles, resulting in venous emptying. VRT90 was 
the time it took for venous pressure to return from its 
lowest point after stimulation (AVP) to 90% of its 
semierect resting pressure. After valvulotomy (Gore 
Eze-Sit valvulotome; Flagstaff, Ariz.) was performed 
through a cutdown in the lateral saphenous vein in 
the paw where the venous cannula had been, it was 
reinserted and secured in place with a silk suture. The 
venous indexes were repeated to confirm insuffi- 
ciency. The cannula was removed, both sides of the 
vein were ligated, and the wound was closed with a 
running, nonabsorbable suture. 
After surgery to create the model was complete 
and with the dog under anesthesia, the opposite 
groin was opened with a vertical incision, thereby 
exposing the femoral vessels. The superficial femoral 
vein (SFV) was dissected free, and all branches were 
ligated. The presence of a valve was noted, and its 
competency was confirmed using a strip test. If no 
valve was found, the external jugular vein was ex- 
posed through a neck incision and one of its valves 
was used (n = 1). A 3 cm section of vein containing a 
competent valve was harvested and sent for cryo- 
preservation (protocol according to CryoLife, Inc., 
Marietta, Ga.). The ends of the in situ veins were 
ligated with 2-0 silk suture. The wounds were closed 
with a running nonabsorbable suture, and the dogs 
were allowed to recover. 
Each dog received intravenous cefazolin (500 
mg) before the operation and then by intramuscular 
injection every 12 hours for three doses. In addition, 
all dogs were given aspirin (325 mg oral) the day 
before surgery and daily thereafter. Veterinary care 
complied with the Guide for the Care and Use of 
Laboratory Animals (National Institute of Health 
Publication, No. 86-23, revised 1985). 
Three weeks later, the cryopreserved valves were 
transplanted into the insufficient SFV of a DEA 
blood type-matched canine model. The SFV and its 
branches in the canine model were carefully dissected 
for 3 cm and controlled with vessel oops. The dog 
was then given heparin systemically (100 U/kg).  
After excising 1.5 cm of the recipient SFV, the 
thawed (per CryoLife protoco!) cryopreserved valve 
was transplanted using a Carrel technique (7-0 Pro- 
lene suture) for both anastomoses. The vessel was 
flushed using a heparin saline solution (2 U/ml) ,  and 
flow was reestablished. 
Next, within the same wound, attention was 
turned toward constructing a dAVF. A 3 cm section 
of femoral artery and SFV below the transplant were 
dissected free and controlled with vessel oops. A 3 
mm branch off the artery (saphenous artery) was 
identified and ligated. After making a small venot- 
omy, the artery branch was sutured to the side of the 
vein with 7-0 Prolene in a running fashion, thus 
completing the dAVF. Early results with this low- 
flow fistula demonstrated poor overall patency of 
the transplant valve, and therefore a higher-flow 
fistula was substituted to more closely reflect that 
used in a previous dog experiment. 2 To achieve a 
higher-flow dAVF, a segment of external jugular vein 
( -0.5 cm in diameter) was used in an end-to-side 
anastomosis to both the femoral artery and SFV with 
a running 7-0 Prolene suture. Fistula flows at midfis- 
tula were assessed using a perivascular flow probe 
(T101 Ultrasonic Bloodflow Meter; Transonic Sys- 
tems, Inc., Ithaca, N.Y.). Before closing the wounds, 
a 2-0 silk suture loop was loosely placed around the 
fistula. Three to 6 weeks later, the dogs were anes- 
thetized and the wound was opened over the fistula. 
The silk suture was tied, thereby closing the fistula as 
evidenced by the disappearance of a thrill. The 
wounds were then closed. One week later, a duplex 
scan (Diasonics, DRF400, Milpitas, Calif.; Serial 
8748, Model 52, 7.5 MHz probe) was performed to 
confirm patency of the SFV and occlusion of the 
dAVF. 
The final venous indexes were obtained 3 weeks 
after fistula ligation (T2). The groin transplant 
wound was then opened, and the transplant valve 
was dissected free. The manual strip test was per- 
formed to confirm patency and competence. One 
half hour before the dogs were killed, heparin (150 
U/kg)  and Evans blue dye (50 mg/kg diluted 50 
mg/ml  in normal saline solution) were given by 
intravenous injection. The valve segment was excised 
and perfusion-fixed for 15 minutes with 2.5 % glutar- 
aldehyde in 0.1 mol/L  phosphate-buffered saline 
solution. After fixation overnight, the valves were 
opened longitudinally, embedded in JB-4 plastic 
(Polysciences, Inc.), sectioned, stained, and exam- 
ined with light microscopy. Any areas of phlebitis, 
valve damage, or scarring were noted. 
A statistical software package (Sigma Stat for 
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Windows vl.0; Jandel Scientific, San Rafael, Calif.) 
was used for all comparisons. The mean and standard 
error of the mean were calculated for VFT, AVP, and 
~V~Tg0. To analyze the effect of  the valve, one-way 
repeated measures analysis of variance with one re- 
peated factor was used. When statistical differences 
were indicated, post hoc comparisons were per- 
formed using Student-Newman-Keuls method to 
identify differences between groups. 
RESULTS 
Two of the four valves aided by a low-flow dAVF 
( -  125 ml/min) exhibited thrombosis and scarring 
on gross examination and were therefore xcluded 
from analysis. The intravenous hemodynamic mea- 
surements for the four valves with high-flow dAVF 
( -710.5  ml/min) and the remaining two low-flow 
dAVF valves are shown in Table I. The VRT90 mea- 
sured after transplantation f  the cryopreserved valve 
was consistent with a normal valve (Fig. 1). The VFT 
was found to be partially corrected. However, the 
AVP appeared to be similar to the insufficient state. 
Gross inspection of these final six valves showed 
no signs of internal scarring, thrombosis, or obstruc- 
tion. Histologic examination demonstrated structur- 
ally normal-appearing thin valves with an endotheli- 
al-like cell covering (Fig. 2). Giant cell granulomas 
were seen surrounding suture material, but no spe- 
cific inflammatory process was noted in the vessel 
wall or perivascular tissues. 
DISCUSSION 
The transplantation f  a competent venous valve 
(autograft) to an incompetent venous system in the 
lower extremity has been studied in our laboratory in 
the past. ~,2 Dalsing et al.1 showed that the transplan- 
tation of  a single SFV valve from one groin to the 
opposite partially corrected insufficiency. In another 
study, it was demonstrated that an external jugular 
vein valve transplanted to the popliteal vein location 
of an incompetent system improved postexercise v - 
2 nous hemodynamics. However, there are no studies 
that investigated the transplantation of a cryopre- 
served venous valve from one dog to a DEA cross- 
matched og with venous insufficiency. 
When analyzing the hemodynamics of  a trans- 
planted valve, the criteria of an incompetent limb as 
outlined in an earlier study were used. 6 Setting the 
specificity at 95%, the venous hemodynamic mea- 
surements in an insufficient venous system and their 
sensitivities are as follows: VRTgo < 0.6 seconds 
(100%); VFT < 7.2 seconds (75%); and an AVP > 
38 mm Hg (89%). Obviously, the assurance of an 
Table I. Numeric data 
Valve 
condition VRTgo (see) Vn  ~ (sec) AVP  (ram Hg) 
T O 3.7 -+ 0.6 39.5 + 4.6 36.3 + 2.2 
T I 0.5 -+ 0.3* 7.8 -+ 4.0* 43.2 + 4.2 
T 2 3.0 + 1.1~ 21.7 --- 8.4* 41.3 + 1.8 
To, Normal  canine l imb; T2, after creation of  venous insufficiency 
model;  7"2, after valve transplantation. 
*p < 0.05 vs To; I"P < 0.05 vs T 1. 
incompetent venous ystem was needed before trans- 
planting a valve. Fig. 1 confirms that all measured 
venous parameters at T 1 were within the incompe- 
tent range. 
The postexercise VRT90 of a single, cryopre- 
served, competent SFV valve was essentially normal. 
The variation noted in the posttransplant measure- 
ments are not statistically different from the pretrans- 
plant valves. These variations are expected because 
factors such as ambient emperature and vasospasm 
affect hese readings as they do in the clinical human 
setting and as we have found in the dog model. 6The 
cryopreserved valve functions quite well to correct 
VRT90 in this model. There is literature that suggests 
that a normal VRT90 is less likely to be associated 
with the clinical sequelae of venous insufficiency and, 
therefore, that this transplantation may improve the 
plight of afflicted individuals. 7 
The cryopreserved valve only partially improved 
the VFT of the incompetent venous system. This 
differs from an earlier study in which the VFT after a 
SFV valve allograft ransplanted to a similar location 
normalized) However, this finding is comparable 
with that found after transplantation of an experi- 
mental Eiseman/Malette-type valve to the same lo- 
cation. 1 One possible explanation is that when the 
dog is rapidly placed in an upright position, the valve 
experiences a large change in the volume and pres- 
sure of blood impacting it. Before reaching the pres- 
sure or flow needed to close this valve, some reflux 
occurs and thereby partially fills the distal vein. When 
the valve does fully close, the distal vein already has 
more blood in it than in a normal state, and therefore 
the arterial inflow more quicldy fills it, resulting in a 
shorter VFT. A native valve appears to respond more 
quickly, preventing this early distal filling and result- 
ing in a longer VFT)  Possibly the cryopreserved 
venous valve experienced some damage that made it 
less responsive than an autogenous valve to this rapid 
change in venous pressure and flow, with a result 
more like that of the thicker Eiseman/Malette valve. 
When evaluating the AVP measurement, one 
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Fig. 1. Mean and standard error for measurements of VII.T90 , VFT, and AVP obtained in 
normal canine limb (To), after all valves are rendered incompetent (T1), and after transplanta- 
tion ofcryopreserved venous valve (T2). *p < 0.05 vs To; +p < 0.05 vs T I. 
notes that it mimics that found for a native valve 
transplant; that is, it was similar to the insufficient 
state. 1 With the transplanted valve located high in 
the groin, there is a long column of blood between 
the valve and the cannula tip at the paw. Therefore, 
the cannula would measure a higher pressure of 
blood with the valve at this location than, for exam- 
ple, a popliteal ocation. This results in an elevated 
AVP that is statistically similar to an incompetent 
venous system. 1 Clinically, it is known that with a 
normal AVP a patient would be less likely to have 
problems with venous ulcers, s The possibility that 
transplantation to the popliteal region may improve 
AVP more dramatically 2 has generated a trend clini- 
cally to transplant to the popliteal vein location in the 
treatment of chronic venous insufficiency. 9-H 
To prevent venous thrombosis early after valve 
transplantation, a dAVF was constructed. This was 
thought appropriate because clinically most sur- 
geons anticoagulate their patients after valvular 
reconstruction. However, this is time-consuming 
and expensive in an animal experiment. We found 
that a dAVF served the same purpose in another 
dog transplant experiment with little need for 
added monitoring. 2 The use of  two types of  fistula 
(low- and high-flow) was a reflection of  an early 
finding that the low-flow fistula was not maintain- 
ing a constantly patent valve, even though other 
authors have found it useful for other types of  
dog bypass experiments. The higher-flow fistulas 
( -700  ml /min)  were useful in a previous experi- 
ment conducted by our group. 2 Kroener and Bern- 
stein 12 have shown that increased flow, in the 
range noted in this study (190 to 1250 ml/min) ,  
provided by a dAVF will not damage adjacent 
valves. Of  the initial eight transplants performed, 
all four of  the high-flow valves and only two of  the 
low-flow valves remained patent and functional. 
The other two low-flow valves appeared to be 
obstructed as a result of  thrombosis. It would seem 
reasonable to conclude that a high-flow dAVF will 
provide better results overall and is required for 
long-term patency and competency in this model. 
In general, the cryopreserved SFV valve per- 
formed much like a native valve to correct venous 
hemodynamics, with a slight decrease in VFT im- 
provement. However, there was a price to pay. 
Transplantation of the native valve required no 
dAVF to maintain a patent and competent venous 
system.i Obviously, the cryopreserved valve-contain- 
ing vein segment is a more thrombogenic challenge 
to this canine model. One must remember that the 
DEA matching of the dog is much like ABO typing 
in the human being) 3 There are many other histo- 
compatibility antigens that may affect rejection of the 
allograft. The transplant may actually be affected by a 
low-grade rejection process, reflected in the need for 
a high-flow dAVF early in the transplant process to 
maintain patency. Interestingly, however, no cellular 
rejection was obvious histologically in the transplant 
specimens at the time of death. Nevertheless, even a 
low-grade process could affect early patency without 
obvious histologic hanges noted after several weeks. 
The reason for simple DEA matching is a practical 
one; currently, clinically used cryopreserved tissues 
(heart, veins, cartilage) are simply ABO-matched. 
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Fig. 2. A, Micrograph of a longitudinal cross-section of a venous valve leaflet shows a thin 
valve without evidence of thrombosis or scarring (hematoxylin & eosin stain; original magnifi- 
cation, 10x). B, Valve at higher magnification demonstrates ndothelial-type c ils lining the 
valve leaflet (hematoxylin & eosin stain; original magnification, 60 x). 
The cost of these tissues would greatly increase if 
more extensive matching was required. Therefore, in 
this initial study, a scenario compatible with currently 
available materials eemed most logical. It does ap- 
pear that if one aggressively supplements the cryo- 
preserved tissue with a high-flow dAVF during the 
early period of transplantation, the results can be 
quite acceptable. Why this demand exists will neces- 
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sitate a more in-depth study into how this cryopre- 
served tissue is perceived by the recipient. 
CONCLUSION 
The transplantation of a single cryopreserved SFV 
valve to the superficial femoral location of an incom- 
petent canine venous system partially corrects venous 
hemodynamics for at least several weeks. The addi- 
tion of a high-flow clAVF is required to maintain a 
patent and competent system on a reliable basis. 
Further studies with regard to other histocompatibil- 
ity antigen affects, its function in the more demand- 
ing popliteal location, and long-term results cannot 
be addressed with this current study. The cryopre- 
served venous valve appears a viable candidate as an 
off-the-shelf valve substitute for the correction of 
venous valvular insufficiency in early experimental 
study. 
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